4Q 2018 Results and preliminary annual report

01. Mar 2019 | 1 min read

Moss, 28 February 2019
 
Gentian Diagnostics AS announces its results for the 4th quarter and 2018 preliminary annual results. The highlights include:
 
  • Record sales revenues of MNOK 11.1 for the quarter
  • 42 % growth in underlying sales revenue compared to 4Q17, 43 % year to date
  • All time high sales results achieved with fCAL® turbo

 

 
Please find the report here:  GDAS 2018 4Q Interim report[2594] or on Oslo Børs NewsWeb.
 
For further information, please contact:
 
Hilja Ibert
CEO, Gentian Diagnostics
E-mail: hilja.ibert@gentian.no
Cell Phone: +47 919 05 242
 
Njaal Kind
CFO, Gentian Diagnostics
E-mail: njaal.kind@gentian.no
Cell Phone. +47 919 06 525

You may also read


Dec 16, 2019 - Kristin Hart

Financial calendar

Financial calendar for Gentian Diagnostics AS

Dec 05, 2019 - Kristin Hart

Gentian Diagnostics presents at DNB conference in New York

Moss 05.12.19 The CEO of Gentian Diagnostics, Dr. Hilja Ibert, will today give a company presentation at the..

Nov 29, 2019 - Kristin Hart

Share capital increase registered

Reference is made to the stock exchange notice from Gentian Diagnostics AS (the "Company") on 25 November..